Paroxetine (Loxamine) Tab 20 mg: Supply issue
Due to a manufacturing delay, there is a supply issue affecting the Loxamine 20 mg tablets (Pharmacode: 2626799)
22 August 2025 | Update
We have added details about the alternative product (Paxtine), including images and a flyer.
The supplier has updated their resupply date to the end of August. As such, only a small amount of Paxtine may be distributed.
Affected product
Viatris, the supplier, advises that there has been a delay at the factory making Loxamine tablets. There may be a brief out of stock of this brand.
- Chemical: Paroxetine
- Presentation: Tab 20 mg
- Brand: Loxamine
- Pharmacode: 2626799
- Subsidy: $4.11
- Measure / Qty: per 90
Schedule listing for paroxetine(external link)
Alternative product
An alternative will be funded from 1 September 2025. Loxamine should be available again before Paxtine is funded, but some stock of Paxtine may be distributed.
The temporary brand is Paxtine. It has the same appearance and the same formulation as the New Zealand Loxamine brand. Paxtine is manufactured by the same supplier and is fully approved for use in New Zealand. The difference is that its packaging is designed for Australia.
Pharmacists, please note the difference in pack size.
Listing details
- Brand: Paxtine
- Presentation: tab 20 mg
- Pharmacode: 2600188
- Subsidy: $1.66
- Measure/Qty: 30
A flyer is available to support pharmacists' conversations with people affected by the supply issue.
- Paroxetine supply issue | Aug 25 [PDF 215 KB]
Expected resolution late August 2025
The supplier expects to have Loxamine tablets available again by late August 2025.
Who to contact
If you have questions about this issue, email enquiry@pharmac.govt.nz
Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is.
Sign up to our email list for regular emails about supply issues and more(external link)